HYDROMER INC

HYDROMER INC, a Patent Owners & Lessors firm rooted in SIC 6794, manages an intellectual-property portfolio centered on specialty polymer formulations and licensing rights tailored for medical device manufacturers, industrial product engineers, and global OEMs seeking advanced surface treatments; the company monetizes its inventions and development know-how through direct licensing agreements and strategic partnerships while safeguarding legacy patents and pursuing new filings, which means the latest Form 8-K filed in March 1999 remains the most recent public disclosure of material events in its history; given the industry’s regulatory overlay, the business must navigate patent term extensions, maintenance fees, and the risk that key patents may be challenged or decline in value, exposing HYDROMER to litigation, enforcement action, and revenue volatility when licensees scale back or regulatory agencies tighten approval requirements for devices that rely on its surface-coating chemistries, so stakeholders keep an eye on filings; CIK 704432 ties the entity to the federal registry, and you can view live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025